Dermatology News

Patients with psoriasis who use biologics are more likely to develop psoriatic arthritis than those on other or no therapies, according to retrospective data published in the Annals of the Rheumatic Diseases.

A novel trichoscopic description of persistent chemotherapy-induced alopecia was reported in a cohort of mostly women with breast cancer, according to a study.

Diagnoses of arthritis, axial symptoms and tendonitis or enthesitis often increase over time before a patient is finally diagnosed with psoriatic arthritis, according to data published in Arthritis Research & Therapy.

Compared to the Rotterdam Early Arthritis Cohort referral rule, the Clinical Arthritis Rule had superior specificity and overall diagnostic performance in recognizing inflammatory arthritis and inflammatory rheumatic disease in primary care.

The FDA has designated Cyltezo the first approved interchangeable biosimilar to treat certain inflammatory diseases, allowing pharmacists to substitute it for Humira without the need for the prescriber to alter the prescription.

Patients with psoriatic arthritis prefer oral over subcutaneous biologics, and prioritize complication avoidance and the ability to work and perform ordinary activities over clinical efficacy, according to data.

Using the most recent EULAR/American College of Rheumatology criteria, researchers at the Mayo Clinic and the Karolinska Institute determined that the incidence and prevalence of dermatomyositis are higher than previously reported.

An immune response may be responsible for “COVID toes,” chilblain-like lesions associated with COVID-19 infection, according to a study published in the British Journal of Dermatology.

Bayer is recalling unexpired Lotrimin AF and Tinactin spray products, while Coppertone is recalling 12 lots of five different aerosol sunscreen sprays, the FDA announced.

A link between condylomas, or genital warts, and the human leukocyte antigen system could suggest a genetic risk for contraction, according to a poster presented at the EADV Congress virtual meeting.